Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifeprunox titration in schizophrenia or bipolar disorder
NCT00139919Phase 2Completed
- Sponsor
- Solvay
- Start
- Jan 2006
- Primary completion
- Oct 2007
- Countries
- 1
01
Overview
A Phase 2 trial of bifeprunox in schizophrenia, bipolar disorder (BD), schizoaffective disorder, sponsored by Solvay. Started Jan 2006; status: completed.
02
Drugs
bifeprunox
03
Conditions
schizophreniabipolar disorder (BD)schizoaffective disorder
Beyond the preview
Go deeper on NCT00139919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139919.